Skip to main content
KyungdongPharm logo

KyungdongPharm — Investor Relations & Filings

Ticker · 011040 ISIN · KR7011040003 KO Manufacturing
Open in API
Filings indexed 303 across all filing types
Latest filing 2020-07-16 Notice of Dividend Amou…
Country KR South Korea
Listing KO 011040

About KyungdongPharm

https://kdpharma.co.kr

KyungdongPharm is a pharmaceutical company engaged in the development, manufacturing, and distribution of medicines. Since its establishment in 1975, the company has focused on producing a broad portfolio of specialized therapeutic drugs and general pharmaceuticals. Its product lines encompass prescription medicines, with a focus on areas such as liver therapy, and over-the-counter products, including its prominent painkiller brand, 'Geunal-N'. The company also manufactures and supplies active pharmaceutical ingredients (APIs) and intermediates. Utilizing advanced production facilities and proprietary technology, KyungdongPharm is dedicated to developing high-quality medicines supported by clinical research to contribute to public health.

Recent filings

Filing Released Lang Actions
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Kyungdong Pharmaceutical regarding the decision to pay a cash dividend. It specifies the dividend amount per share, the total dividend amount, the record date, and the payment date. This aligns perfectly with the definition of a 'Notice of Dividend Amount' (DIV).
2020-07-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as the '5% Rule' report). It details the change in share ownership by IVA Fiduciary Trust & IVA International Fund in Kyungdong Pharmaceutical Co., Ltd. This document is a mandatory disclosure filed with the Financial Supervisory Service (FSS) and the Korea Exchange (KRX) when a shareholder's stake crosses specific thresholds or changes significantly. It does not fit into categories like 'Annual Report' or 'Earnings Release', but rather falls under the 'Major Shareholding Notification' category.
2020-07-10 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as the '5% rule' report). It details the change in shareholding percentage by International Value Advisers, LLC in Kyungdong Pharmaceutical Co., Ltd. This document type is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-07-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea. It details changes in share ownership by a major shareholder (Ryu Gi-seong) and their special related parties in Kyungdong Pharmaceutical Co., Ltd. This type of filing is specifically designed to notify the market when a shareholder's stake crosses certain thresholds or changes significantly, which falls under the 'Major Shareholding Notification' category.
2020-06-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by corporate insiders to disclose their personal share transactions. According to the provided definitions, reports of personal share transactions by company directors and executives are classified as 'Director's Dealing' (DIRS).
2020-06-25 Korean
유형자산취득결정(자율공시)
Capital/Financing Update Classification · 95% confidence The document is a regulatory disclosure from Kyungdong Pharmaceutical regarding the acquisition of tangible assets (land and building). It details the purpose, amount, counterparty, and board approval date. Since this is a specific corporate event disclosure that does not fit into categories like financial reports, dividends, or share transactions, it falls under the general regulatory filing category.
2020-06-25 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.